The issue of whether people should be able to profit from their own cells is a complex and controversial one. On one hand, some argue that individuals have a right to benefit financially from their own cells, which are a part of their own bodies. Supporters of this argument point out that many people donate their cells for scientific research, and that the researchers and companies that use these cells often profit significantly from their work.
On the other hand, opponents argue that allowing people to profit from their own cells could lead to exploitation and inequality, particularly for those who are economically disadvantaged. They argue that access to life-saving treatments should not be dependent on an individual's ability to pay, and that allowing people to profit from their own cells could exacerbate existing social and economic inequalities.